Congenital disorders of glycosylation: the rapidly growing tip of the iceberg

In addition to many other organs, the brain is affected in 10 of the 11 known congenital disorders of N-linked glycosylation, mostly to a severe degree. Because a large number of enzymes, transporters and other proteins are involved in glycosylation (both N-linked and O-linked), it is expected that the great majority of congenital disorders of glycosylation (CDG) are yet to be identified. Many neurological patients with a CDG escape diagnosis for that reason, but also because existing screening methods fail to detect all patients with a known CDG. These disorders should be looked for in any patient, regardless of age, with an unexplained neurological disorder.

[1]  T. Sato,et al.  Beta-1,4-galactosylation of N-glycans is a complex process. , 1999, Biochimica et biophysica acta.

[2]  M. Pineda,et al.  Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[3]  E. Schaftingen,et al.  High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). , 2001, American journal of human genetics.

[4]  J. Marth,et al.  Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Hennet,et al.  Congenital disorders of glycosylation: genetic model systems lead the way. , 2001, Trends in cell biology.

[6]  R. Contreras,et al.  Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. , 2001, Glycobiology.

[7]  J. Jaeken,et al.  Increased α3‐fucosylation of α1‐acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG‐Ia) , 2001 .

[8]  W. Schima,et al.  Budd-Chiari syndrome associated with coagulation abnormalities in a child with carbohydrate deficient glycoprotein syndrome type Ix. , 2000, The Journal of pediatrics.

[9]  L. Sturla,et al.  Impairment of the Golgi GDP-l-Fucose Transport and Unresponsiveness to Fucose Replacement Therapy in LAD II Patients , 2001, Pediatric Research.

[10]  H. Freeze,et al.  Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. , 2000, The American journal of pathology.

[11]  P. Codogno,et al.  Defect in N-glycosylation of proteins is tissue-dependent in congenital disorders of glycosylation Ia. , 2000, Glycobiology.

[12]  G. Matthijs,et al.  Congenital disorders of glycosylation. , 2000, Trends in biochemical sciences.

[13]  J. White,et al.  MUC 1: a genetic susceptibility to infertility? , 2001, The Lancet.

[14]  G. Dacremont,et al.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. , 2000, American journal of human genetics.

[15]  J. Hewitt,et al.  Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse , 2001, Nature Genetics.

[16]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[17]  Rita Gerardy-Schahn,et al.  The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter , 2001, Nature Genetics.

[18]  M. Durán,et al.  A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. , 1998, Biochemical and biophysical research communications.

[19]  H. Freeze,et al.  Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. , 2001, Molecular genetics and metabolism.

[20]  Amos Etzioni,et al.  Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency , 2001, Nature Genetics.